Bard Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Bard Associates’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,625	Closed	-$56.4K	–	162
2025 Q2	$56.4K	Sell	12,625 -1,600	-11%	-$7.21K	0.02%	162
2025 Q1	$64.9K	Hold	14,225	–	–	0.02%	166
2024 Q4	$86.5K	Sell	14,225 -5,500	-28%	-$37.5K	0.03%	167
2024 Q3	$155K	Sell	19,725 -125	-0.6%	-$1.26K	0.05%	161
2024 Q2	$223K	Hold	19,850	–	–	0.09%	151
2024 Q1	$251K	Sell	19,850 -20	-0.1%	-$263	0.09%	149
2023 Q4	$273K	Sell	19,870 -700	-3%	-$8.19K	0.1%	143
2023 Q3	$232K	Hold	20,570	–	–	0.1%	149
2023 Q2	$275K	Sell	20,570 -65	-0.3%	-$762	0.11%	144
2023 Q1	$240K	Hold	20,635	–	–	0.1%	154
2022 Q4	$248K	Buy	+20,635	New	+$268K	0.11%	149

Other funds holding BIOX

FSC

Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return

Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

BAM

Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Bard Associates's BIOX Position: Q3 2025 in Review

Bard Associates sold out of Bioceres Crop Solutions (BIOX) in Q3 2025, closing a stake of 12,625 shares — an estimated $56.4K sold.

Bard Associates first reported a position in BIOX in Q4 2022 and held it in 11 quarters. The position peaked at $275K in Q2 2023. 38 funds tracked by Wall St. Rank hold BIOX as of Q3 2025.

Bard Associates reported no remaining Bioceres Crop Solutions position as of Q3 2025 after selling out during the quarter.
Bard Associates sold 12,625 Bioceres Crop Solutions shares in Q3 2025, an estimated $56.4K.
Bard Associates first reported a position in Bioceres Crop Solutions in Q4 2022 and held it in 11 quarters.
Bard Associates's Bioceres Crop Solutions position peaked at $275K in Q2 2023.
38 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2025.

Based on Bard Associates's 13F filing for Q3 2025, filed 14 Nov 2025.